Cargando…
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis
BACKGROUND: Multiple sclerosis (MS) is a chronic neuroinflammatory disease affecting about 2.8 million people worldwide. Disease course after the most common diagnoses of relapsing-remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) is highly variable and cannot be reliably pr...
Autores principales: | Hapfelmeier, Alexander, On, Begum Irmak, Mühlau, Mark, Kirschke, Jan S., Berthele, Achim, Gasperi, Christiane, Mansmann, Ulrich, Wuschek, Alexander, Bussas, Matthias, Boeker, Martin, Bayas, Antonios, Senel, Makbule, Havla, Joachim, Kowarik, Markus C., Kuhn, Klaus, Gatz, Ingrid, Spengler, Helmut, Wiestler, Benedikt, Grundl, Lioba, Sepp, Dominik, Hemmer, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041597/ https://www.ncbi.nlm.nih.gov/pubmed/36993939 http://dx.doi.org/10.1177/17562864231161892 |
Ejemplares similares
-
Lesion location across diagnostic regions in multiple sclerosis
por: Pongratz, Viola, et al.
Publicado: (2023) -
Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
por: Bussas, Matthias, et al.
Publicado: (2021) -
Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis
por: Wuschek, Alexander, et al.
Publicado: (2022) -
Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume
por: Lauerer, Markus, et al.
Publicado: (2022) -
Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing–Remitting Multiple Sclerosis
por: Grahl, S., et al.
Publicado: (2021)